84 completed, 24 unknown, 5 terminated, 4 withdrawn. 19 Phase 2, 13 Phase 1, 5 Not applicable, 5 Phase 3.
Follow Mutation analysis: new trials by email Literature Review of Mutation analysis trials Research Report on Mutation analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Natural History Study of FDXR Mutation-related Mitochondriopathy Mutation analysis - Neurodegenerative Disease, Hereditary, Mitochondrial Diseases | Completed | State University of New York at Buffalo | 33 | 2020-11-03 | 2024-03-08 | |
| Natural History Study of SLC25A46 Mutation-related Mitochondriopathy Mutation analysis - Neurodegenerative Disease, Hereditary, Mitochondrial Diseases | Completed | State University of New York at Buffalo | 9 | 2020-11-03 | 2024-03-08 | |
| A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX) Mutation Analysis - Xanthomatosis, Cerebrotendinous | Unknown | TRPHARM | 800 | 2019-12-01 | 2021-04-01 | |
| Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer Mutation analysis - Breast Cancer | Not applicable | Unknown | Fudan University | 100 | 2016-01-01 | 2016-02-02 |
| High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia Chemosensitivity Assay, Cytology Specimen Collection Procedure, Gene Expression Analysis - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia | Not applicable | Completed | University of Washington | 34 | 2015-09-11 | 2022-06-30 |
| Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors mutation analysis, cytology specimen collection procedure, laboratory biomarker analysis - Unspecified Adult Solid Tumor, Protocol Specific | Recruiting | Stanford University | 100 | 2014-07-28 | 2025-12-24 | |
| Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia gene expression analysis, mutation analysis, flow cytometry - Leukemia | Completed | Children's Oncology Group | 149 | 2013-02-01 | 2016-05-18 | |
| Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial mutation analysis, polymerase chain reaction, polymorphism analysis - Head and Neck Cancer | Completed | Eastern Cooperative Oncology Group | 183 | 2012-06-01 | 2017-05-17 | |
| Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma mutation analysis, nucleic acid sequencing, laboratory biomarker analysis - Sarcoma | Completed | Children's Oncology Group | 58 | 2012-04-01 | 2016-05-18 | |
| Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors RNA analysis, gene expression analysis, mutation analysis - Childhood Germ Cell Tumor, Leydig Cell Tumor | Completed | Children's Oncology Group | 50 | 2012-04-01 | 2016-07-14 | |
| Studying Gene Expression in Samples From Patients With Rhabdoid Tumors DNA analysis, gene expression analysis, mutation analysis - Brain and Central Nervous System Tumors, Kidney Cancer | Completed | Children's Oncology Group | 25 | 2012-03-01 | 2016-07-14 | |
| Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial gene mapping, microarray analysis, mutation analysis - Leukemia | Completed | Children's Oncology Group | 10 | 2012-02-01 | 2016-05-18 | |
| Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia mutation analysis, protein analysis, laboratory biomarker analysis - Leukemia | Completed | Eastern Cooperative Oncology Group | 220 | 2012-01-03 | 2017-05-19 | |
| Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma DNA analysis, RNA analysis, cytogenetic analysis - Lymphoma, Nonneoplastic Condition | Completed | Children's Oncology Group | 50 | 2011-12-01 | 2016-05-17 | |
| Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma fluorescence in situ hybridization, gene expression analysis, microarray analysis - Neuroblastoma | Completed | Children's Oncology Group | 5 | 2011-12-01 | 2016-07-11 | |
| Biomarkers in Tissue Samples From Patients With Ewing Sarcoma DNA analysis, comparative genomic hybridization, gene expression analysis - Sarcoma | Completed | Children's Oncology Group | 166 | 2011-12-01 | 2015-05-12 | |
| S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin DNA analysis, RNA analysis, gene expression analysis - Leukemia | Completed | SWOG Cancer Research Network | 365 | 2011-12-01 | 2015-03-06 | |
| Biomarkers in Patients With Head and Neck Cancer cetuximab, cisplatin, DNA analysis - Head and Neck Cancer | Completed | ECOG-ACRIN Cancer Research Group | 70 | 2011-11-21 | 2017-05-19 | |
| Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression DNA methylation analysis, RNA analysis, mutation analysis - Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor | Completed | Children's Oncology Group | 90 | 2011-10-01 | 2016-05-18 | |
| Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1 DNA analysis, RNA analysis, gene expression analysis - Sarcoma | Completed | Children's Oncology Group | 20 | 2011-09-01 | 2016-05-18 |
Showing 20 of 119. Sign in to see all of them.
Leukemia (29) · Carcinoma, Non-Small-Cell Lung (15) · Leukemia, Myeloid, Acute (13) · Colonic Neoplasms (12) · Lung Neoplasms (12) · Breast Neoplasms (11) · Colorectal Neoplasms (9) · Congenital Abnormalities (9) · Rectal Neoplasms (9) · Kidney Neoplasms (8) · Leukemia, Erythroblastic, Acute (7) · Leukemia, Megakaryoblastic, Acute (7) · Leukemia, Monocytic, Acute (7) · Leukemia, Myelomonocytic, Acute (7) · Melanoma (7)
Children's Oncology Group (22) · Alliance for Clinical Trials in Oncology (11) · ECOG-ACRIN Cancer Research Group (7) · Case Comprehensive Cancer Center (5) · Eastern Cooperative Oncology Group (5) · Leeds Cancer Centre at St. James's University Hospital (5) · City of Hope Medical Center (4) · National Cancer Institute (NCI) (4) · SWOG Cancer Research Network (4) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (4) · University of Nebraska (3) · Abramson Cancer Center at Penn Medicine (2) · Cancer Trials Ireland (2) · Medical Research Council (2) · National Institutes of Health Clinical Center (CC) (2)
United States (49) · United Kingdom (13) · Ireland (3) · Australia (2) · Canada (2) · France (2) · Italy (2) · Belgium (1) · China (1) · Germany (1) · Iceland (1) · Israel (1) · Portugal (1) · Puerto Rico (1) · Singapore (1)
Julia Newton Bishop, MD (4) · Adolfo A. Ferrando, MD, PhD (2) · Anjali Advani, MD (2) · Balazs Halmos, MD (2) · Brenda Cooper, MD (2) · Christine B. Ambrosone, PhD (2) · Dana A. Hill, MD (2) · Jill Kolesar, PharmD (2) · Ralph Hauke, MD (2) · Taosheng Huang (2) · Wendell G. Yarbrough, MD, FACS (2) · William D. Figg, PharmD (2) · Afshin Dowlati, MD (1) · Alan K. Burnett, MD, FRCP (1) · Alberto S. Pappo, MD (1)
PMID 12622604, PMID 12860943, PMID 14701766, PMID 14726676, PMID 15386381, PMID 15662127, PMID 16299243, PMID 18090584, PMID 18094376, PMID 18223210, PMID 19770416, PMID 20309628, PMID 20442368, PMID 21169260, PMID 21204803, PMID 24360787, PMID 24383844, PMID 24831979, PMID 25361995, PMID 25527568, PMID 25870087, PMID 26715442, PMID 26882907, PMID 26898607, PMID 28925785, PMID 31375516, PMID 32994442, PMID 33555272, PMID 34162404, PMID 34847232, PMID 36823396, PMID 37196637, PMID 38017103, PMID 38702786, PMID 39283025
P30CA043703 (4), U10CA031946 (4), P30CA036727 (3), U10CA032102 (3), P30CA033572 (2), P30CA068485 (2), U01CA062475 (2), 2008 (1), P30CA012197 (1), P30CA014236 (1), P30CA014520 (1), P30CA015704 (1), P30CA093373 (1), R01CA129382 (1), RC1CA145707 (1)